United Therapeutics | UTHR - Ebitda


United Therapeutics reported $436.8M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Baxter International USD 462M 137M Jun/2025
Bayer EUR 1.51B 1.28B Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Halozyme Therapeutics USD 248.25M 22.74M Sep/2025
Insmed USD -297.13M 71.11M Jun/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
J&J USD 9.52B 389M Sep/2025
Moderna USD -208M 552M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
PTC Therapeutics USD -33.11M 1B Jun/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025